speb/financial-data huggingface dataset:
Financial ratios for EUREKAFORB.NS — quarterly report dated 2025-09-30
Total revenue: 87043900.789177
Gross profit: 49701961.668545656
Operating income: 9158804.96054115
Net income: 7093291.995490417
Capital expenditures: 0
Depreciation & amortization: 1851713.6414881623
Net tangible assets: -72218579.48139797
Owner earnings: 8945005.63697858
Return on net tangible assets (%): -12.386017145743818
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.425591882750846
P/E ratio: 71.42716316471451
Shares outstanding: 193506816
Book value: 509738489.28974074
P/B ratio: 2.4392818126782694
Market cap (USD): 1243395826.1465614
Debt to equity: 0.020090678501636358
Current ratio: 0.9783818980200621
Quick ratio: 0.6664547018061322
Effective tax rate (%): 25.95223187805406
Interest coverage ratio: 36.16551662734274
COGS to revenue (%): 42.90012141238323
Buyback yield (%): 0
Inventory turnover: 0.8472158027515719
Receivables turnover: 2.1012319518791167
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4680224363376146
Revenue growth (%): 22.37450612653089
Rule of 40 score: 22.37450612653089
Financial ratios for EUREKAFORB.NS — quarterly report dated 2025-12-31
Total revenue: 71894374.51264343
Gross profit: 43996825.22000668
Operating income: 5731346.775091901
Net income: 1116508.8559652446
Capital expenditures: 0
Depreciation & amortization: 1908755.7090341987
Owner earnings: 3025264.5649994435
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.893171438119639
P/E ratio: 72.00644100615153
Shares outstanding: 193506816
Market cap (USD): 1333875657.1326723
Effective tax rate (%): 27.109903434573635
Interest coverage ratio: 18.79188429087987
COGS to revenue (%): 38.80352180785806
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -17.40446618221556
Rule of 40 score: -17.40446618221556
Financial ratios for FBRT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.05
Shares outstanding: 76963009
Market cap (USD): 696515231.45
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FBRT — annual report dated 2022-12-31
Total revenue: 367360000
Gross profit: 206834000
Operating income: 101141000
Net income: 14431000
Capital expenditures: 0
Operating cash flow: 152515000
Depreciation & amortization: 5408000
Net tangible assets: 1508149000
Owner earnings: 19839000
Return on net tangible assets (%): 1.3154535791887938
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.7
P/E ratio: 46.398598731896605
Shares outstanding: 76963009
Book value: 1578388000
P/B ratio: 0.42421646534312224
Market cap (USD): 669578178.3
Debt to equity: 2.818237340881963
Current ratio: 11.007199259964338
Quick ratio: 11.007199259964338
Effective tax rate (%): -2.8879559930515346
COGS to revenue (%): 43.71869555749129
SG&A to revenue (%): 17.467878919860627
Free cash flow (dilution-adjusted): 149996000
Buyback yield (%): 2.4760364864477244
Retained earnings: -299225000
Receivables turnover: 0.06903899248475537
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7801925700840486
FCF margin (%): 40.830792682926834
Rule of 40 score: 40.830792682926834
Financial ratios for FBRT — annual report dated 2023-12-31
Total revenue: 569527000
Gross profit: 263950000
Operating income: 154766000
Net income: 145215000
Capital expenditures: 0
Operating cash flow: 197387000
Depreciation & amortization: 8412000
Net tangible assets: 1516321000
Owner earnings: 153627000
Return on net tangible assets (%): 10.1315618526684
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.14
P/E ratio: 5.374134292325174
Shares outstanding: 76963009
Book value: 1586209000
P/B ratio: 0.4919937481504644
Market cap (USD): 780404911.26
Debt to equity: 2.6369507423044505
Current ratio: 20.076363192778434
Quick ratio: 20.076363192778434
Effective tax rate (%): -1.9449461030532196
COGS to revenue (%): 53.654523841714266
SG&A to revenue (%): 11.99556825225143
Free cash flow (dilution-adjusted): 192626000
Buyback yield (%): 1.6023733089800904
Retained earnings: -298942000
Receivables turnover: 0.11194785737634574
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.722521341217245
FCF margin (%): 33.822101498260835
Revenue growth (%): 55.032393292682926
Rule of 40 score: 88.85449479094376
Financial ratios for FBRT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.64
Shares outstanding: 76963009
Market cap (USD): 818886415.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FBRT — annual report dated 2024-12-31
Total revenue: 548925000
Gross profit: 210454000
Operating income: 110779000
Net income: 95878000
Capital expenditures: 0
Operating cash flow: 57233000
Depreciation & amortization: 5630000
Net tangible assets: 1472728000
Owner earnings: 101508000
Return on net tangible assets (%): 6.89251511480735
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.52
P/E ratio: 8.444594742068045
Shares outstanding: 76963009
Book value: 1520057000
P/B ratio: 0.5326450617838673
Market cap (USD): 809650854.68
Debt to equity: 2.837358730626549
Current ratio: 17.746080638155036
Quick ratio: 17.746080638155036
Effective tax rate (%): 1.197566374047026
COGS to revenue (%): 61.66070045998998
SG&A to revenue (%): 10.629138771234686
Free cash flow (dilution-adjusted): 49060000
Buyback yield (%): 0.6011233078885089
Retained earnings: -348074000
Receivables turnover: 0.1056489696182106
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9439993963334277
FCF margin (%): 8.937468688800838
Revenue growth (%): -3.6173877621254134
Rule of 40 score: 5.320080926675424
Financial ratios for FBRT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.52
Shares outstanding: 76963009
Market cap (USD): 809650854.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FBRT — quarterly report dated 2025-03-31
Total revenue: 120587000
Gross profit: 49994000
Operating income: 31787000
Net income: 24058000
Capital expenditures: 0
Operating cash flow: 116238000
Depreciation & amortization: 1380000
Net tangible assets: 1460522000
Owner earnings: 25438000
Return on net tangible assets (%): 1.7417060475638162
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.99
P/E ratio: 8.789420036058692
Shares outstanding: 76963009
Book value: 1505311000
P/B ratio: 0.5618928373671621
Market cap (USD): 845823468.91
Debt to equity: 2.6442848022767387
Current ratio: 17.779888754976334
Quick ratio: 17.779888754976334
Effective tax rate (%): 2.6848392791165483
COGS to revenue (%): 58.54113627505453
SG&A to revenue (%): 15.528207849934073
Free cash flow (dilution-adjusted): 113992000
Buyback yield (%): 0
Retained earnings: -360456000
Receivables turnover: 0.02493528224468202
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5919968771498927
FCF margin (%): 94.53091958502989
Rule of 40 score: 94.53091958502989
Financial ratios for FBRT — quarterly report dated 2025-06-30
Total revenue: 119507000
Gross profit: 49294000
Operating income: 32965000
Net income: 24384000
Capital expenditures: 0
Operating cash flow: 11819000
Depreciation & amortization: 1381000
Net tangible assets: 1450326000
Owner earnings: 25765000
Return on net tangible assets (%): 1.7764971461588637
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.53
P/E ratio: 15.140941244581148
Shares outstanding: 76963009
Book value: 1495638000
P/B ratio: 0.490397727103751
Market cap (USD): 733457475.77
Debt to equity: 2.6526365337066857
Current ratio: 24.90308173291648
Quick ratio: 24.90308173291648
Effective tax rate (%): -0.5691660480079188
COGS to revenue (%): 58.75220698369134
SG&A to revenue (%): 13.752332499351501
Free cash flow (dilution-adjusted): 9503000
Buyback yield (%): 0
Retained earnings: -373710000
Receivables turnover: 0.02538944489814649
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6077360288925802
FCF margin (%): 7.951835457337227
Revenue growth (%): -0.8956189307305099
Rule of 40 score: 7.0562165266067165
Financial ratios for FBRT — quarterly report dated 2025-09-30
Total revenue: 136618000
Gross profit: 60126000
Operating income: 1721000
Net income: 17616000
Capital expenditures: 0
Operating cash flow: -148126000
Depreciation & amortization: 3432000
Net tangible assets: 1054791000
Owner earnings: 21048000
Return on net tangible assets (%): 1.995466400452791
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.99
P/E ratio: 11.639172543976507
Shares outstanding: 76963009
Book value: 1566021000
P/B ratio: 0.49096433566982817
Market cap (USD): 768860459.91
Debt to equity: 2.7824601330378074
Current ratio: 23.372835199259562
Quick ratio: 23.372835199259562
Effective tax rate (%): -19.698308079092204
COGS to revenue (%): 55.989693890995326
SG&A to revenue (%): 40.65496493873428
Free cash flow (dilution-adjusted): -150543000
Buyback yield (%): 0
Retained earnings: -392841000
Receivables turnover: 0.02674190473972065
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.028713276495171716
FCF margin (%): -110.1926539694623
Revenue growth (%): 14.31798974118671
Rule of 40 score: -95.87466422827559
Financial ratios for FBRT — annual report dated 2025-12-31
Total revenue: 500999000
Gross profit: 212672000
Operating income: 85022000
Net income: 84085000
Capital expenditures: 360000
Operating cash flow: 291940000
Depreciation & amortization: 9593000
Net tangible assets: 1021713000
Owner earnings: 93318000
Return on net tangible assets (%): 9.133484647841419
Capex to operating income (%): 0.4234198207522759
Buffett classification: The Great
Stock price: 9.55
P/E ratio: 8.741115965392163
Shares outstanding: 76963009
Book value: 1531477000
P/B ratio: 0.4799267216876258
Market cap (USD): 734996735.95
Debt to equity: 2.7752816398809776
Current ratio: 18.43354599395673
Quick ratio: 18.43354599395673
Effective tax rate (%): 4.415191715263331
COGS to revenue (%): 57.55041427228398
SG&A to revenue (%): 25.92959267383767
Free cash flow (dilution-adjusted): 282462000
Buyback yield (%): 1.9547025581590272
Retained earnings: -411101000
Receivables turnover: 0.10321682787890026
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.469980054938823
FCF margin (%): 56.37975325300051
Revenue growth (%): -8.730883089675274
Rule of 40 score: 47.648870163325235
Financial ratios for FBRT — quarterly report dated 2025-12-31
Total revenue: 124503000
Gross profit: 53474000
Operating income: 18766000
Net income: 18380000
Capital expenditures: 180000
Operating cash flow: 312009000
Depreciation & amortization: 3400000
Net tangible assets: 1021713000
Owner earnings: 21600000
Return on net tangible assets (%): 2.1140966200880285
Capex to operating income (%): 0.959181498454652
Buffett classification: The Great
Stock price: 9.55
P/E ratio: 8.704573011558777
Shares outstanding: 76963009
Book value: 1531477000
P/B ratio: 0.4799267216876258
Market cap (USD): 734996735.95
Debt to equity: 2.7752816398809776
Current ratio: 18.43354599395673
Quick ratio: 18.43354599395673
Effective tax rate (%): 25.427029658782
COGS to revenue (%): 57.050030922949645
SG&A to revenue (%): 31.488397869930846
Free cash flow (dilution-adjusted): 309510000
Buyback yield (%): 1.9547025581590272
Retained earnings: -411101000
Receivables turnover: 0.025650360023486512
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.32445303228554906
FCF margin (%): 248.59641936338886
Revenue growth (%): -8.867791945424468
Rule of 40 score: 239.7286274179644
Financial ratios for HESTERBIO.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.099960437821444
Shares outstanding: 8506865
Market cap (USD): 298590624.94988793
Buyback yield (%): 0
Retained earnings: 24371884.478438612
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HESTERBIO.NS — annual report dated 2023-03-31
Total revenue: 32410596.83313033
Gross profit: 21957612.667478684
Operating income: 5062728.3800243605
Net income: 3414738.1242387337
Capital expenditures: 3045.066991473813
Operating cash flow: 2874056.0292326435
Depreciation & amortization: 2520706.455542022
Net tangible assets: 33714250.9135201
Owner earnings: 5932399.512789282
Return on net tangible assets (%): 17.596118412971382
Capex to operating income (%): 0.060146758089738975
Buffett classification: The Great
Stock price: 18.275030450669917
P/E ratio: 45.527127193508115
Shares outstanding: 8506865
Book value: 35145676.004872106
P/B ratio: 4.4233952675483295
Market cap (USD): 155463216.91473815
Debt to equity: 0.9501154062090621
Current ratio: 1.5305858933663314
Quick ratio: 0.9602275784150212
Effective tax rate (%): 30.181301987348707
Interest coverage ratio: 8.072441250728296
COGS to revenue (%): 32.25174846199233
SG&A to revenue (%): 11.89968845244672
Free cash flow (dilution-adjusted): -6597563.946406822
Buyback yield (%): 0
Retained earnings: 24731059.683313034
Inventory turnover: 1.0118971819360925
Receivables turnover: 3.3415504012256534
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.973794770464443
FCF margin (%): -20.35619393365428
Rule of 40 score: -20.35619393365428
Financial ratios for HESTERBIO.NS — annual report dated 2024-03-31
Total revenue: 36520685.93356518
Gross profit: 23307830.675140902
Operating income: 5070152.296438422
Net income: 2538194.0280609187
Capital expenditures: 6595.515049766159
Operating cash flow: 5778030.938961506
Depreciation & amortization: 2059479.5539033457
Net tangible assets: 34519846.50437702
Owner earnings: 4591078.066914499
Return on net tangible assets (%): 13.299821788988439
Capex to operating income (%): 0.13008514664143803
Buffett classification: The Great
Stock price: 16.558181381957773
P/E ratio: 55.495447591702984
Shares outstanding: 8506865
Book value: 36320302.19450773
P/B ratio: 3.8782225133338355
Market cap (USD): 140858213.66182822
Debt to equity: 0.8068609162195626
Current ratio: 2.0348054459951457
Quick ratio: 1.3182076759708738
Effective tax rate (%): 33.758958470253184
Interest coverage ratio: 4.636473297510692
COGS to revenue (%): 36.179099380717524
SG&A to revenue (%): 10.016877581711793
Free cash flow (dilution-adjusted): 2852380.381340688
Buyback yield (%): 0
Retained earnings: 25793140.664348245
Inventory turnover: 1.4578002408012596
Receivables turnover: 3.8724140123339055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.592368125701459
FCF margin (%): 7.810314369586203
Revenue growth (%): 12.681312601542366
Rule of 40 score: 20.491626971128568
Financial ratios for HESTERBIO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 35575489.72766364
Buffett classification: The Gruesome
Stock price: 29.134854276158624
Shares outstanding: 8506865
Book value: 37535594.83994267
P/B ratio: 6.602966415713067
Market cap (USD): 247846272.12195414
Debt to equity: 0.7765268195819861
Current ratio: 1.7521074337804483
Quick ratio: 1.2221933082570398
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HESTERBIO.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.751136496095114
Shares outstanding: 8506865
Market cap (USD): 236075171.76885417
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HESTERBIO.NS — quarterly report dated 2025-03-31
Total revenue: 9577390.69441197
Gross profit: 7152560.205751695
Operating income: 1754150.1052139348
Net income: 180149.6375964461
Capital expenditures: 0
Depreciation & amortization: 488192.6584054243
Net tangible assets: 35959551.08721066
Owner earnings: 668342.2960018704
Return on net tangible assets (%): 1.8585946592630638
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.526315789473685
P/E ratio: 171.48717174391203
Shares outstanding: 8506865
Book value: 38187514.61304652
P/B ratio: 3.2359636027792966
Market cap (USD): 123573407.36842106
Debt to equity: 0.652827439263323
Current ratio: 1.5590970092024539
Quick ratio: 0.9969085506134969
Effective tax rate (%): 58.85180240320427
Interest coverage ratio: 2.6699288256227756
COGS to revenue (%): 25.318278913640523
Buyback yield (%): 0
Retained earnings: 27716389.992985737
Inventory turnover: 0.2947269704590989
Receivables turnover: 1.1194845656659516
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.840774629355113
Rule of 40 score: 0
Financial ratios for HESTERBIO.NS — annual report dated 2025-03-31
Total revenue: 36369184.00748188
Gross profit: 24371405.190554123
Operating income: 5289104.512508768
Net income: 3369885.4337152205
Capital expenditures: 32031.797989244795
Operating cash flow: 7541617.956511573
Depreciation & amortization: 1964227.2620996025
Net tangible assets: 35959551.08721066
Owner earnings: 5302080.897825578
Return on net tangible assets (%): 14.744569210463004
Capex to operating income (%): 0.6056185487257697
Buffett classification: The Great
Stock price: 14.526315789473685
P/E ratio: 36.66991350272233
Shares outstanding: 8506865
Book value: 38187514.61304652
P/B ratio: 3.2359636027792966
Market cap (USD): 123573407.36842106
Debt to equity: 0.652827439263323
Current ratio: 1.5590970092024539
Quick ratio: 0.9969085506134969
Effective tax rate (%): 27.15372368653812
Interest coverage ratio: 5.424820143884892
COGS to revenue (%): 32.98885895944095
SG&A to revenue (%): 11.27411588482234
Free cash flow (dilution-adjusted): 5134440.028057049
Buyback yield (%): 0
Retained earnings: 27716389.992985737
Inventory turnover: 1.4582747204342328
Receivables turnover: 4.25113075798363
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.565489273969568
FCF margin (%): 14.117556299863065
Revenue growth (%): -0.4148386652947698
Rule of 40 score: 13.702717634568295
Financial ratios for HESTERBIO.NS — quarterly report dated 2025-06-30
Total revenue: 9841446.290662298
Gross profit: 7213082.143692956
Operating income: 2180201.2637491226
Net income: 2023870.8167563775
Capital expenditures: 0
Depreciation & amortization: 489351.7435057337
Owner earnings: 2513222.560262111
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 21.536391294172713
P/E ratio: 83.12408034366383
Shares outstanding: 8506865
Market cap (USD): 183207173.32670256
Effective tax rate (%): 14.321097736166838
Interest coverage ratio: 10.293922651933702
COGS to revenue (%): 26.707092325069855
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.7570724080870304
Rule of 40 score: 2.7570724080870304
Financial ratios for HESTERBIO.NS — quarterly report dated 2025-09-30
Total revenue: 8001014.656144306
Gross profit: 5822998.8726042835
Operating income: 830214.2051860202
Net income: 1628974.0698985343
Capital expenditures: 0
Depreciation & amortization: 490868.09470124013
Net tangible assets: 37220856.82074408
Owner earnings: 2119842.1645997744
Return on net tangible assets (%): 5.6953072703536884
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 21.531116121758735
P/E ratio: 47.78569261924514
Shares outstanding: 8506865
Book value: 39575648.25253664
P/B ratio: 4.62815661232751
Market cap (USD): 183162298.14712512
Debt to equity: 0.6085244818195285
Current ratio: 1.4408821178750524
Quick ratio: 0.975004774130578
Effective tax rate (%): 15.878140408546606
Interest coverage ratio: 3.3366560942455825
COGS to revenue (%): 27.22174470543477
Buyback yield (%): 0
Inventory turnover: 0.2932942658913905
Receivables turnover: 0.7660481633798559
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3795506531509167
Revenue growth (%): -18.700824860104344
Rule of 40 score: -18.700824860104344
Financial ratios for HESTERBIO.NS — quarterly report dated 2025-12-31
Total revenue: 8623705.023950094
Gross profit: 6314693.1046006465
Operating income: 1488470.5358137463
Net income: 1037094.7978166426
Capital expenditures: 0
Depreciation & amortization: 493594.7421187479
Owner earnings: 1530689.5399353905
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 17.743009914225244
P/E ratio: 30.992735461755917
Shares outstanding: 8506865
Market cap (USD): 150937390.03397572
Effective tax rate (%): 31.15942028985507
Interest coverage ratio: 7.333699231613611
COGS to revenue (%): 26.775172770134994
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 7.782642509317227
Rule of 40 score: 7.782642509317227
Financial ratios for HHFA.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.65909090909091
Shares outstanding: 72514938
Market cap (USD): 1498092696.409091
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HHFA.DE — annual report dated 2022-12-31
Total revenue: 1679096808.5106385
Gross profit: 406197872.34042555
Operating income: 235307446.80851066
Net income: 141552127.65957448
Capital expenditures: 176072340.42553192
Operating cash flow: 297147872.34042555
Depreciation & amortization: 187075531.91489363
Net tangible assets: 717053191.4893618
Owner earnings: 152555319.1489362
Return on net tangible assets (%): 21.275314155156302
Capex to operating income (%): 74.82650583889794
Buffett classification: The Good
Stock price: 11.776595744680852
P/E ratio: 6.032965554077515
Shares outstanding: 72514938
Book value: 929057446.8085108
P/B ratio: 0.919188703788099
Market cap (USD): 853979110.2765958
Debt to equity: 0.7819089124873756
Current ratio: 1.5120603431602795
Quick ratio: 1.4060668576182624
Effective tax rate (%): 31.47999382048509
Interest coverage ratio: 6.648301773369401
COGS to revenue (%): 75.80854955583389
SG&A to revenue (%): 4.338958824748107
Free cash flow (dilution-adjusted): 106607446.80851065
Buyback yield (%): 0
Retained earnings: 602619148.9361702
Inventory turnover: 34.65576666859758
Receivables turnover: 7.657177371232298
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.0459115108814
FCF margin (%): 6.349094719742313
Rule of 40 score: 6.349094719742313
Financial ratios for HHFA.DE — annual report dated 2023-12-31
Total revenue: 1607523333.3333333
Gross profit: 270745555.5555555
Operating income: 106305555.55555555
Net income: 47080000
Capital expenditures: 287135555.5555555
Operating cash flow: 249305555.55555555
Depreciation & amortization: 198223333.33333334
Net tangible assets: 632954444.4444444
Owner earnings: -41832222.22222218
Return on net tangible assets (%): -6.609041549418154
Capex to operating income (%): 270.10399790958974
Buffett classification: The Gruesome
Stock price: 18.433333333333334
P/E ratio: 28.391929137638066
Shares outstanding: 72514938
Book value: 897003333.333333
P/B ratio: 1.490175090913821
Market cap (USD): 1336692023.8
Debt to equity: 1.153636243145387
Current ratio: 1.2554727030625832
Quick ratio: 1.1720033894201671
Effective tax rate (%): 33.588288768377176
Interest coverage ratio: 1.8330299837149153
COGS to revenue (%): 83.15759715946753
SG&A to revenue (%): 5.358138917631056
Free cash flow (dilution-adjusted): -58511111.11111111
Buyback yield (%): 0
Retained earnings: 588547777.7777778
Inventory turnover: 34.89572758650694
Receivables turnover: 8.789724054970291
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6838854701473402
FCF margin (%): -3.6398296620543267
Revenue growth (%): -4.262617546202771
Rule of 40 score: -7.902447208257097
Financial ratios for HHFA.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.522222222222222
Shares outstanding: 72514938
Market cap (USD): 1343137796.0666666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HHFA.DE — annual report dated 2024-12-31
Total revenue: 1664864583.3333335
Gross profit: 306362500
Operating income: 144592708.33333334
Net income: 58752083.333333336
Capital expenditures: 254912500
Operating cash flow: 204111458.33333334
Depreciation & amortization: 182038541.6666667
Net tangible assets: 560272916.6666667
Owner earnings: -14121874.99999997
Return on net tangible assets (%): -2.5205350071207797
Capex to operating income (%): 176.29692599183048
Buffett classification: The Gruesome
Stock price: 18.322916666666668
P/E ratio: 22.61511576575299
Shares outstanding: 72514938
Book value: 858088541.6666665
P/B ratio: 1.5484243193386467
Market cap (USD): 1328685166.0625
Debt to equity: 1.8292522746171547
Current ratio: 1.4378214713246482
Quick ratio: 1.354555739236055
Effective tax rate (%): 38.02931417144615
Interest coverage ratio: 2.4563617058927623
COGS to revenue (%): 81.5983532194185
SG&A to revenue (%): 4.396378584344322
Free cash flow (dilution-adjusted): -74316666.66666667
Buyback yield (%): 0
Retained earnings: 561777083.3333334
Inventory turnover: 34.339933645794936
Receivables turnover: 8.472817875791874
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.9086043882482615
FCF margin (%): -4.46382651241655
Revenue growth (%): 3.567055532630957
Rule of 40 score: -0.8967709797855932
Financial ratios for HHFA.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.322916666666668
Shares outstanding: 72514938
Market cap (USD): 1328685166.0625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HHFA.DE — quarterly report dated 2025-03-31
Total revenue: 473481521.73913044
Gross profit: 77129347.82608695
Operating income: 35373913.04347826
Net income: 14332608.695652174
Capital expenditures: 72563043.47826086
Operating cash flow: 67302173.91304347
Depreciation & amortization: 46439130.43478261
Net tangible assets: 584632608.6956521
Owner earnings: -11791304.347826079
Return on net tangible assets (%): -2.0168742168065403
Capex to operating income (%): 205.13151425762044
Buffett classification: The Gruesome
Stock price: 18.967391304347824
P/E ratio: 23.99108274116487
Shares outstanding: 72514938
Book value: 895396739.1304345
P/B ratio: 1.5361003054269122
Market cap (USD): 1375419204.4565215
Debt to equity: 0
Current ratio: 1.4378214713246482
Quick ratio: 1.3545557392360548
Effective tax rate (%): 34.7275157154878
Interest coverage ratio: 1.8945162417045058
COGS to revenue (%): 83.71016728534927
Free cash flow (dilution-adjusted): -12320652.173913043
Buyback yield (%): 0
Retained earnings: 586202173.9130435
Inventory turnover: 9.601453473063351
Receivables turnover: 2.309237416174093
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1508304303838472
FCF margin (%): -2.6021400219925024
Rule of 40 score: -2.6021400219925024
Financial ratios for HHFA.DE — quarterly report dated 2025-06-30
Total revenue: 528138823.5294118
Gross profit: 101696470.5882353
Operating income: 55068235.29411765
Net income: 22282352.94117647
Capital expenditures: 76348235.29411764
Operating cash flow: 79157647.05882353
Depreciation & amortization: 50736470.5882353
Net tangible assets: 657368235.2941177
Owner earnings: -3329411.7647058815
Return on net tangible assets (%): -0.5064759119698332
Capex to operating income (%): 138.6429670141856
Buffett classification: The Gruesome
Stock price: 22.294117647058822
P/E ratio: 44.15289506448875
Shares outstanding: 72514938
Book value: 1015156470.5882354
P/B ratio: 1.592519582724425
Market cap (USD): 1616656558.9411764
Debt to equity: 0
Current ratio: 1.3115392684932983
Quick ratio: 1.2454162465859742
Effective tax rate (%): 38.24632340952816
Interest coverage ratio: 2.279647396873326
COGS to revenue (%): 80.74436756824186
Free cash flow (dilution-adjusted): -2623529.411764706
Buyback yield (%): 0
Retained earnings: 654263529.4117647
Inventory turnover: 10.178193356358632
Receivables turnover: 1.9920569415231149
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5817660305539563
FCF margin (%): -0.4967499632449579
Revenue growth (%): 11.543703245170223
Rule of 40 score: 11.046953281925266
Financial ratios for HHFA.DE — quarterly report dated 2025-09-30
Total revenue: 525727058.8235294
Gross profit: 90563529.41176471
Operating income: 44441176.47058824
Net income: 24268235.29411765
Capital expenditures: 119689411.76470588
Operating cash flow: 101371764.70588236
Depreciation & amortization: 51464705.88235294
Net tangible assets: 665154117.6470588
Owner earnings: -43956470.58823529
Return on net tangible assets (%): -6.6084640269128245
Capex to operating income (%): 269.32097948378555
Buffett classification: The Gruesome
Stock price: 24.823529411764707
P/E ratio: 29.566067272665407
Shares outstanding: 72514938
Book value: 1003650588.2352943
P/B ratio: 1.793529259421195
Market cap (USD): 1800076696.235294
Debt to equity: 0
Current ratio: 1.2030583719205765
Quick ratio: 1.1371114418731587
Effective tax rate (%): 20.29595858125338
Interest coverage ratio: 2.215022868535241
COGS to revenue (%): 82.77366023076166
Free cash flow (dilution-adjusted): -22001176.470588237
Buyback yield (%): 0
Retained earnings: 658823529.4117647
Inventory turnover: 10.070487340049006
Receivables turnover: 2.0567688604343966
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2580646020752488
FCF margin (%): -4.184904714591334
Revenue growth (%): -0.45665355365568205
Rule of 40 score: -4.6415582682470164
Financial ratios for HHFA.DE — quarterly report dated 2025-12-31
Total revenue: 499764705.88235295
Gross profit: 146810588.23529413
Operating income: 58991764.705882356
Net income: -24787058.82352941
Capital expenditures: 105761176.47058824
Operating cash flow: 68271764.70588236
Depreciation & amortization: 54784705.88235294
Net tangible assets: 634010588.2352941
Owner earnings: -75763529.41176471
Return on net tangible assets (%): -11.949883932166657
Capex to operating income (%): 179.2812556089584
Buffett classification: The Gruesome
Stock price: 25.176470588235293
P/E ratio: 50.577992535704944
Shares outstanding: 72514938
Book value: 984922352.9411764
P/B ratio: 1.853618407900772
Market cap (USD): 1825670203.764706
Debt to equity: 1.966260702545677
Current ratio: 1.1236051502145923
Quick ratio: 1.0487332758503765
Effective tax rate (%): 173.48027761308546
Interest coverage ratio: 3.4443604890781705
COGS to revenue (%): 70.62405838041431
Free cash flow (dilution-adjusted): -48871764.705882356
Buyback yield (%): 0
Retained earnings: 642321176.4705882
Inventory turnover: 7.764058901167155
Receivables turnover: 2.0632276301538193
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6948923381861678
FCF margin (%): -9.778954802259888
Revenue growth (%): -4.9383710625956665
Rule of 40 score: -14.717325864855553
Financial ratios for HHFA.DE — annual report dated 2025-12-31
Total revenue: 2066104705.882353
Gross profit: 422551764.7058824
Operating income: 196788235.29411766
Net income: 37276470.5882353
Capital expenditures: 380337647.0588235
Operating cash flow: 321645882.35294116
Depreciation & amortization: 207249411.7647059
Net tangible assets: 634010588.2352941
Owner earnings: -135811764.70588234
Return on net tangible assets (%): -21.421056245117448
Capex to operating income (%): 193.2725533568482
Buffett classification: The Gruesome
Stock price: 25.176470588235293
P/E ratio: 48.97647698279943
Shares outstanding: 72514938
Book value: 984922352.9411764
P/B ratio: 1.853618407900772
Market cap (USD): 1825670203.764706
Debt to equity: 1.966260702545677
Current ratio: 1.1236051502145923
Quick ratio: 1.0487332758503765
Effective tax rate (%): 69.94545885700735
Interest coverage ratio: 2.4129076929734725
COGS to revenue (%): 79.54838573752596
SG&A to revenue (%): 4.649100979450389
Free cash flow (dilution-adjusted): -86831764.70588236
Buyback yield (%): 0
Retained earnings: 642321176.4705882
Inventory turnover: 36.15382624673274
Receivables turnover: 8.529702609633253
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.653922609504822
FCF margin (%): -4.2026797799097935
Revenue growth (%): 24.100465981783977
Rule of 40 score: 19.897786201874183
Financial ratios for INAC.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 3321995
Buffett classification: The Gruesome
Stock price: 0.015
Shares outstanding: 49420712
Book value: 50359387.5
P/B ratio: 0.014720406994624388
Market cap (USD): 741310.6799999999
Debt to equity: 0.01199947576804821
Current ratio: 1.5168615118307056
Quick ratio: 1.5168615118307056
Buyback yield (%): 0
Retained earnings: -9665676.25
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDOCO.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.88764341289727
Shares outstanding: 92173705
Market cap (USD): 450512202.08558613
Buyback yield (%): 0
Retained earnings: 74353699.0636951
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDOCO.NS — annual report dated 2023-03-31
Total revenue: 199762241.16930574
Gross profit: 134072399.5127893
Operating income: 24072947.624847747
Net income: 17326613.885505483
Capital expenditures: 141193.66626065774
Operating cash flow: 21781717.417783193
Depreciation & amortization: 8600024.360535933
Net tangible assets: 110107539.58587089
Owner earnings: 25785444.57978076
Return on net tangible assets (%): 23.418418644865966
Capex to operating income (%): 0.5865242115798054
Buffett classification: The Great
Stock price: 3.9182704019488432
P/E ratio: 20.84432091151939
Shares outstanding: 92173705
Book value: 125243800.24360538
P/B ratio: 2.8836676900332567
Market cap (USD): 361161500.1394641
Debt to equity: 0.3237055016495962
Current ratio: 1.9165007879728724
Quick ratio: 1.1485853001246153
Effective tax rate (%): 26.21507831493095
Interest coverage ratio: 8.32153278063856
COGS to revenue (%): 32.884013150834605
R&D to revenue (%): 4.937038428143566
SG&A to revenue (%): 10.173598577602606
Free cash flow (dilution-adjusted): -3542046.2850182704
Buyback yield (%): 0
Retained earnings: 83651607.7953715
Inventory turnover: 1.6544097820301824
Receivables turnover: 4.67329495264723
Capitalized R&D asset: 9862338.611449452
ROCI (R&D-adjusted, %): 19.139438105168587
FCF margin (%): -1.7731310303113077
Rule of 40 score: -1.7731310303113077
Financial ratios for INDOCO.NS — annual report dated 2024-03-31
Total revenue: 214440040.77227485
Gross profit: 144636107.44693607
Operating income: 17131658.472238876
Net income: 11807183.115481472
Capital expenditures: 202026.62189710996
Operating cash flow: 18633781.028900348
Depreciation & amortization: 11016344.885477874
Net tangible assets: 110550965.34356637
Owner earnings: 22621501.379062235
Return on net tangible assets (%): 20.46250913210928
Capex to operating income (%): 1.1792589854886817
Buffett classification: The Great
Stock price: 3.9238243761996157
P/E ratio: 30.63164405821821
Shares outstanding: 92173705
Book value: 133169037.05480273
P/B ratio: 2.715897317593382
Market cap (USD): 361673430.5236324
Debt to equity: 0.6050926225258142
Current ratio: 1.5590784098603268
Quick ratio: 0.9824868542805286
Effective tax rate (%): 28.56784132372596
Interest coverage ratio: 4.089954966690238
COGS to revenue (%): 32.55172544919782
R&D to revenue (%): 5.4332042195138115
SG&A to revenue (%): 11.848957801786195
Free cash flow (dilution-adjusted): -32795838.82959587
Buyback yield (%): 0
Retained earnings: 91682731.74241516
Inventory turnover: 1.6486977555029054
Receivables turnover: 4.402269455846103
Capitalized R&D asset: 18258732.21323751
ROCI (R&D-adjusted, %): 10.69762106452427
Rosenberg metric: 1.0711159239536845
FCF margin (%): -15.29371040570893
Revenue growth (%): 7.347634626570465
Rule of 40 score: -7.946075779138465
Financial ratios for INDOCO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 107861920.68800765
Buffett classification: The Gruesome
Stock price: 4.279741997133302
Shares outstanding: 92173705
Book value: 130060917.34352604
P/B ratio: 3.0330377824258177
Market cap (USD): 394479676.3198758
Debt to equity: 0.7663081910604572
Current ratio: 1.2921490028596758
Quick ratio: 0.8142209568051548
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDOCO.NS — quarterly report dated 2025-03-31
Total revenue: 44878419.452887535
Gross profit: 32490063.128360998
Operating income: -3455693.2429272854
Net income: -4721767.594108019
Capital expenditures: 0
Depreciation & amortization: 3364507.8325929386
Net tangible assets: 97002197.8021978
Owner earnings: -1357259.7615150805
Return on net tangible assets (%): -1.3992051646940402
Buffett classification: The Gruesome
Stock price: 2.7158361535768467
Shares outstanding: 92173705
Book value: 119052899.22843114
P/B ratio: 2.1026676550548524
Market cap (USD): 250328680.44812697
Debt to equity: 0.9756360724426135
Current ratio: 1.2392891531372758
Quick ratio: 0.7202824525924698
Interest coverage ratio: -1.6440489432703005
COGS to revenue (%): 27.60426163744823
R&D to revenue (%): 4.529943473390815
Buyback yield (%): 0
Retained earnings: 78579039.04606032
Inventory turnover: 0.25269801692745253
Receivables turnover: 1.089317262056437
Capitalized R&D asset: 2032967.0329670329
ROCI (R&D-adjusted, %): -1.0959898402758497
Rule of 40 score: 0
Financial ratios for INDOCO.NS — annual report dated 2025-03-31
Total revenue: 191873977.08674303
Gross profit: 133634556.93242927
Operating income: -1704465.7470189384
Net income: -8620528.40776245
Capital expenditures: 415010.5213935001
Operating cash flow: 10610240.823006779
Depreciation & amortization: 13308393.733925648
Net tangible assets: 97002197.8021978
Owner earnings: 4272854.8047696985
Buffett classification: The Gruesome
Stock price: 2.7158361535768467
Shares outstanding: 92173705
Book value: 119052899.22843114
P/B ratio: 2.1026676550548524
Market cap (USD): 250328680.44812697
Debt to equity: 0.9756360724426135
Current ratio: 1.2392891531372758
Quick ratio: 0.7202824525924698
Interest coverage ratio: -0.22014192963913634
COGS to revenue (%): 30.35295407880387
R&D to revenue (%): 4.63111333158674
SG&A to revenue (%): 15.868981106324902
Free cash flow (dilution-adjusted): -19819967.266775776
Buyback yield (%): 0
Retained earnings: 78579039.04606032
Inventory turnover: 1.1879692183912267
Receivables turnover: 4.657286016933522
Capitalized R&D asset: 19946619.854677632
ROCI (R&D-adjusted, %): -1.408516701556979
Rosenberg metric: -0.9442608565119304
FCF margin (%): -10.329679703160318
Revenue growth (%): -10.523250976946006
Rule of 40 score: -20.852930680106326
Financial ratios for INDOCO.NS — quarterly report dated 2025-06-30
Total revenue: 50208284.57758016
Gross profit: 34414930.961853504
Operating income: -1424058.0388485843
Net income: -4187924.1750526563
Capital expenditures: 0
Depreciation & amortization: 3475310.086590218
Owner earnings: -712614.0884624384
Buffett classification: The Gruesome
Stock price: 3.7136672127311026
Shares outstanding: 92173705
Market cap (USD): 342302466.1344489
Interest coverage ratio: -0.46592649310872897
COGS to revenue (%): 31.45567260184581
R&D to revenue (%): 5.048009695161741
Buyback yield (%): 0
Capitalized R&D asset: 3896606.985338556
ROCI (R&D-adjusted, %): -10.574182510258126
Rosenberg metric: 0.9468268802584762
Revenue growth (%): 11.876231805105819
Rule of 40 score: 11.876231805105819
Financial ratios for INDOCO.NS — quarterly report dated 2025-09-30
Total revenue: 53193912.063134156
Gross profit: 36808342.72829763
Operating income: 1217587.3731679819
Net income: -894024.8027057496
Capital expenditures: 0
Depreciation & amortization: 3635851.1837655017
Net tangible assets: 88511837.65501691
Owner earnings: 2741826.381059752
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.291431792559188
Shares outstanding: 92173705
Book value: 109843291.9954904
P/B ratio: 2.7619662299216885
Market cap (USD): 303383463.0749718
Debt to equity: 1.025043364021718
Current ratio: 1.0977209278716815
Quick ratio: 0.6666362113598294
Interest coverage ratio: 0.4397394136807818
COGS to revenue (%): 30.803467350528795
R&D to revenue (%): 4.622427569251637
Buyback yield (%): 0
Inventory turnover: 0.3422663903541824
Receivables turnover: 1.0424417833944588
Capitalized R&D asset: 4827856.956326839
ROCI (R&D-adjusted, %): 0.7558767595655151
Rosenberg metric: 0.9443258059109642
Revenue growth (%): 5.946483753972321
Rule of 40 score: 5.946483753972321
Financial ratios for INDOCO.NS — quarterly report dated 2025-12-31
Total revenue: 48383647.098139696
Gross profit: 34969366.15795923
Operating income: -55697.894619583385
Net income: -3280605.9930934613
Capital expenditures: 0
Depreciation & amortization: 3565779.213545728
Owner earnings: 285173.22045226675
Buffett classification: The Gruesome
Stock price: 2.613345215550852
Shares outstanding: 92173705
Market cap (USD): 240881710.96134564
Interest coverage ratio: -0.01950078003120125
COGS to revenue (%): 27.724823870700373
R&D to revenue (%): 4.215591472118616
Buyback yield (%): 0
Capitalized R&D asset: 4523477.732909612
ROCI (R&D-adjusted, %): -7.966945459354719
Rosenberg metric: -0.7479010627648598
Revenue growth (%): -9.042886259775951
Rule of 40 score: -9.042886259775951
Financial ratios for INO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 59.88
Shares outstanding: 82273237
Market cap (USD): 4926521431.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INO — annual report dated 2022-12-31
Total revenue: 516076.14
Operating income: -267573520
Net income: -279818065
Capital expenditures: 969153
Operating cash flow: -216215421
Depreciation & amortization: 5496026
Net tangible assets: 209719524
Owner earnings: -275291192
Return on net tangible assets (%): -131.26636316416585
Buffett classification: The Gruesome
Stock price: 18.72
Shares outstanding: 82273237
Book value: 222362756
P/B ratio: 6.9263172679870895
Market cap (USD): 1540154996.6399999
Debt to equity: 0.14424357557431966
Current ratio: 3.254350654272325
Quick ratio: 3.254350654272325
Interest coverage ratio: -213.38418057469505
COGS to revenue (%): 0
R&D to revenue (%): 36361.0111872252
SG&A to revenue (%): 17475.189804357164
Free cash flow (dilution-adjusted): -239739993
Buyback yield (%): 0
Retained earnings: -1487847784
Receivables turnover: 0.04396546630254546
Capitalized R&D asset: 187650503
ROCI (R&D-adjusted, %): -32.430704072981776
FCF margin (%): -46454.38423097801
Rule of 40 score: -46454.38423097801
Financial ratios for INO — annual report dated 2023-12-31
Total revenue: 832010
Operating income: -133426657
Net income: -135117352
Capital expenditures: 5898365
Operating cash flow: -124365551
Depreciation & amortization: 3503538
Net tangible assets: 117349129
Owner earnings: -137512179
Return on net tangible assets (%): -117.18210452162793
Buffett classification: The Gruesome
Stock price: 6.12
Shares outstanding: 82273237
Book value: 117349129
P/B ratio: 4.290719622128598
Market cap (USD): 503512210.44
Debt to equity: 0.25743047483548004
Current ratio: 3.5967178752249107
Quick ratio: 3.5967178752249107
Interest coverage ratio: -109.11666444496966
COGS to revenue (%): 0
R&D to revenue (%): 10417.730916695713
SG&A to revenue (%): 5718.934147426113
Free cash flow (dilution-adjusted): -135758935
Buyback yield (%): 0
Retained earnings: -1622965136
Receivables turnover: 0.3459173101261086
Capitalized R&D asset: 212402400.01
ROCI (R&D-adjusted, %): -40.55137963119327
FCF margin (%): -16316.983569909016
Revenue growth (%): 61.21845896615178
Rule of 40 score: -16255.765110942864
Financial ratios for INO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.78
Shares outstanding: 82273237
Market cap (USD): 475539309.86
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INO — annual report dated 2024-12-31
Total revenue: 217756
Operating income: -112398922
Net income: -107254126
Capital expenditures: 428513
Operating cash flow: -104076553
Depreciation & amortization: 3130042
Net tangible assets: 68503795
Owner earnings: -104552597
Return on net tangible assets (%): -152.62307292610578
Buffett classification: The Gruesome
Stock price: 1.83
Shares outstanding: 82273237
Book value: 68503795
P/B ratio: 2.1978347872552173
Market cap (USD): 150560023.71
Debt to equity: 0.1732048129596324
Current ratio: 2.769382383034347
Quick ratio: 2.769382383034347
Interest coverage ratio: -632.0476064622427
COGS to revenue (%): 0
R&D to revenue (%): 34727.098220026084
SG&A to revenue (%): 16989.81336909201
Free cash flow (dilution-adjusted): -111159493
Buyback yield (%): 0
Retained earnings: -1730219262
Receivables turnover: 0.1816061968748749
Capitalized R&D asset: 195618303.20000002
ROCI (R&D-adjusted, %): -56.099952208891565
FCF margin (%): -51047.72910964566
Revenue growth (%): -73.82771841684595
Rule of 40 score: -51121.55682806251
Financial ratios for INO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.83
Shares outstanding: 82273237
Market cap (USD): 150560023.71
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INO — quarterly report dated 2025-03-31
Total revenue: 65343
Operating income: -25050529
Net income: -19694697
Capital expenditures: 59373
Operating cash flow: -26874027
Depreciation & amortization: 743450
Net tangible assets: 51250724
Owner earnings: -19010620
Return on net tangible assets (%): -37.093368671240626
Buffett classification: The Gruesome
Stock price: 1.63
Shares outstanding: 82273237
Book value: 51250724
P/B ratio: 2.6166533044489286
Market cap (USD): 134105376.30999999
Debt to equity: 0.21991800545100593
Current ratio: 2.6309058699712518
Quick ratio: 2.6309058699712518
COGS to revenue (%): 0
R&D to revenue (%): 24625.28809512878
SG&A to revenue (%): 13811.686026047168
Free cash flow (dilution-adjusted): -28332749
Buyback yield (%): 0
Retained earnings: -1749913959
Receivables turnover: 0.049871130184844424
Capitalized R&D asset: 16090902
ROCI (R&D-adjusted, %): -18.837304326841934
FCF margin (%): -43360.03703533661
Rule of 40 score: -43360.03703533661
Financial ratios for INO — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -23084519
Net income: -23519412
Capital expenditures: 30930
Operating cash flow: -20811359
Depreciation & amortization: 741670
Net tangible assets: 28530905
Owner earnings: -22808672
Return on net tangible assets (%): -79.94373820248603
Buffett classification: The Gruesome
Stock price: 2.04
Shares outstanding: 82273237
Book value: 28530905
P/B ratio: 5.882652635098676
Market cap (USD): 167837403.48
Debt to equity: 0.3735678205791229
Current ratio: 1.661971652861884
Quick ratio: 1.661971652861884
Free cash flow (dilution-adjusted): -21677081
Buyback yield (%): 0
Retained earnings: -1773433371
Receivables turnover: 0
Capitalized R&D asset: 25302311.34
ROCI (R&D-adjusted, %): -30.35037224637443
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for INO — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -21210455
Net income: -45496672
Capital expenditures: 67951
Operating cash flow: -21573495
Depreciation & amortization: 749656
Net tangible assets: -7719977
Owner earnings: -44814967
Buffett classification: The Gruesome
Stock price: 2.34
Shares outstanding: 82273237
Book value: -7719977
Market cap (USD): 192519374.57999998
Debt to equity: -1.2979607322664304
Current ratio: 0.7902783597179969
Quick ratio: 0.7902783597179969
Free cash flow (dilution-adjusted): -22398532
Buyback yield (%): 0
Retained earnings: -1818930043
Receivables turnover: 0
Capitalized R&D asset: 28372669.35
ROCI (R&D-adjusted, %): -80.63766657900244
Rule of 40 score: 0
Financial ratios for INO — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -17476601
Net income: 3764880
Capital expenditures: 127444
Operating cash flow: -19370549
Depreciation & amortization: 754054
Net tangible assets: 24096276
Owner earnings: 4391490
Return on net tangible assets (%): 18.224766349787828
Buffett classification: The Gruesome
Stock price: 1.74
P/E ratio: 9.505975780104544
Shares outstanding: 82273237
Book value: 24096276
P/B ratio: 5.940977451453493
Market cap (USD): 143155432.38
Debt to equity: 0.3887665463327196
Current ratio: 1.3997107529662935
Quick ratio: 1.3997107529662935
Free cash flow (dilution-adjusted): -20262554
Buyback yield (%): 0
Retained earnings: -1815165163
Receivables turnover: 0
Capitalized R&D asset: 23986630.740000002
ROCI (R&D-adjusted, %): -36.466003912915106
Rule of 40 score: 0